Sponsor or institution
Clinical trials and research at Kidney Cancer Research Bureau
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Kidney Cancer Research Bureau that are recruiting, in Russia. 1 was first registered in the last 30 days. By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 1Country
All recruiting trials (2)
-
Lenvatinib and Pembrolizumab With or Without SBRT for Metastatic Kidney Cancer
This study tests whether adding SBRT to standard lenvatinib plus pembrolizumab helps people with metastatic kidney cancer who have stable disease after initial treatment.
-
OM-RCA-01 (anti-FGFR1 antibody) for metastatic tumors that express FGFR1
This trial will try OM-RCA-01, an IV antibody given every two weeks, in adults with metastatic cancers whose tumors test positive for FGFR1 and who have progressed after standard treatments.
Quick answers
How many clinical trials run by Kidney Cancer Research Bureau are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Russia. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.